The purposes of this study are to assess rapidly innovative treatment methods in patients
with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS
and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish
and maintain the required infrastructure to perform multiple therapeutic trials that may
involve investigational drugs, approved agents not currently used for treatment of ARDS, or
treatments currently used but whose efficacy has not been well documented.
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
Completed
GlaxoSmithKline
Phase 3
2004-09-01
This study evaluates the effect of cumulative dose administration of albuterol sulfate
inhalation aerosol delivered with valved holding chamber and facemask. This is a four week
study in birth to 23 month old subjects who are experiencing acute wheezing due to
obstructive airways disease.
(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)
Completed
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3
2006-11-01
Asthma is a common, serious illness among children in the United States. It can be
effectively controlled through the use of preventative medications and "rescue" medications,
which are used to control symptoms. This study will evaluate the impact and severity of
asthma exacerbations that occur in children with mild persistent asthma who are receiving
various combinations of medications for daily and rescue use.
(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)
Completed
Milton S. Hershey Medical Center
Phase 3
2006-11-01
Asthma is a common, serious illness among children in the United States. It can be
effectively controlled through the use of preventative medications and "rescue" medications,
which are used to control symptoms. This study will evaluate the impact and severity of
asthma exacerbations that occur in children with mild persistent asthma who are receiving
various combinations of medications for daily and rescue use.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
